Teleflex Incorporated
TFX
Rank in Stocks
#3228
Teleflex Incorporated is a global medical technology company dedicated to... Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
Share Price
$129.59
Last synced: 2026-10-19
Market Cap
$5.49B
Change (1 day)
-0.44%
Change (1 year)
-0.73%
Country
US
Trade Teleflex Incorporated (TFX)
Category
Healthcare
P/E ratio for Teleflex Incorporated (TFX)
P/E ratio as of October 2026 TTM: -5.30
According to Teleflex Incorporated latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -5.30. At the end of 2023 the company had a P/E ratio of 32.87.
P/E ratio history for Teleflex Incorporated from 2000 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | -5.30 | -104.43% |
| 2024 | 119.64 | 263.93% |
| 2023 | 32.87 | 1.97% |
| 2022 | 32.24 | 1.85% |
| 2021 | 31.65 | -44.52% |
| 2020 | 57.06 | 51.40% |
| 2019 | 37.69 | -35.92% |
| 2018 | 58.81 | -19.89% |
| 2017 | 73.41 | 149.60% |
| 2016 | 29.41 | 31.84% |
| 2015 | 22.31 | -11.85% |
| 2014 | 25.31 | -1.03% |
| 2013 | 25.57 | -266.80% |
| 2012 | -15.33 | -299.68% |
| 2011 | 7.68 | -28.10% |
| 2010 | 10.68 | 51.16% |
| 2009 | 7.06 | -57.34% |
| 2008 | 16.56 | -1.95% |
| 2007 | 16.89 | -8.27% |
| 2006 | 18.41 | -3.49% |
| 2005 | 19.08 | -91.25% |
| 2004 | 218.11 | 1,134.01% |
| 2003 | 17.68 | 32.21% |
| 2002 | 13.37 | -18.05% |
| 2001 | 16.31 | 5.58% |
| 2000 | 15.45 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 47.48 | -996.61% |
US
|
|
| 27.43 | -617.86% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | -1,174.29% |
US
|
|
| - | - |
CH
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.